WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete... WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …
Cytokinetics - Funding, Financials, Valuation & Investors
WebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … incompetent\\u0027s 8h
Cytokinetics Inc Company Profile - GlobalData
Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebHistorical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Compare CYTK With Other Stocks From: To: Zoom: 0 10 20 30 40 Stock Price 0 2 4 6 8 TTM Sales per Share WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. incompetent\\u0027s a4